title: Prostate MR Imaging: An Update.
abstract: Improvements in prostate MR imaging techniques and the introduction of MR imaging-targeted biopsies have had central roles in prostate cancer (PCa) management. The role of MR imaging has progressed from largely staging patients with biopsy-proven PCa to detecting, characterizing, and guiding the biopsy of suspected PCa. These diagnostic advances, combined with improved therapeutic interventions, have led to a more sophisticated and individually tailored approach to patients' unique PCa profile. This review discusses the MR imaging, a standardized reporting scheme, and the role of fusion-targeted prostate biopsy.
authors.affiliation: Department of Radiology, NYU Langone Medical Center, 550 1st Avenue, New York, NY 10016, USA. Electronic address: hs2926@cumc.columbia.edu.
authors.forename: Hiram
authors.initials: H
authors.lastname: Shaish
authors.affiliation: Division of Urologic Oncology, Department of Urology, NYU Langone Medical Center, 550 1st Avenue, New York, NY 10016, USA.
authors.forename: Samir S
authors.initials: SS
authors.lastname: Taneja
authors.affiliation: Department of Radiology, NYU Langone Medical Center, 550 1st Avenue, New York, NY 10016, USA.
authors.forename: Andrew B
authors.initials: AB
authors.lastname: Rosenkrantz
mesh_terms: D006801:Humans; D061705:Image-Guided Biopsy; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D011467:Prostate / Q000000981:diagnostic imaging* / Q000473:pathology*; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology*
keywords: Diffusion-weighted imaging; MR imaging; PI-RADS; Prostate biopsy; Prostate cancer